Contribution of T Lymphocytes to the Development of Bleomycin‐Induced Pulmonary Fibrosisa
- 1 October 1996
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 796 (1) , 194-202
- https://doi.org/10.1111/j.1749-6632.1996.tb32581.x
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Cyclosporin-sensitive expression of cytokine mRNA in mouse macrophages responding to bacteriaMolecular Immunology, 1995
- Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in miceEuropean Respiratory Journal, 1994
- Interleukin-1 (IL-1) production in a mouse tissue chamber model of inflammation. II. Identification of (tissue) macrophages as the IL-1 producing cells and the effect of anti-inflammatory drugsInflammation Research, 1993
- Cyclosporin A, FK-506, and Rapamycin: Pharmacologic Probes of Lymphocyte Signal TransductionAnnual Review of Immunology, 1992
- Lung Cytokine Production in Bleomycin-Induced Pulmonary FibrosisExperimental Lung Research, 1992
- Stimulation of rat endothelial cell transforming growth factor-beta production by bleomycin.Journal of Clinical Investigation, 1991
- Alteration of bronchoalveolar lavage cell populations following bleomycin treatment in miceToxicology and Applied Pharmacology, 1989
- Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation.The Journal of Experimental Medicine, 1989
- Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis.The Journal of Experimental Medicine, 1989
- The many faces of an increase in lung collagen*1Fundamental and Applied Toxicology, 1985